세계의 블린시토(Blincyto) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Blincyto (blinatumomab) is a prescription medication designed for the treatment of specific blood cancers. As a bi-specific T-cell engager (BiTE) antibody construct, it operates by linking cancerous B-cells with T-cells (a type of immune cell), harnessing the immune system to identify and eliminate the cancerous B-cells.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of blincyto are prefilled and non-prefilled formulations. The prefilled option comes in ready-to-use syringes or vials, simplifying preparation and administration. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used to treat acute lymphoblastic leukemia and other hematological disorders. Key users include hospitals, clinics, and research institutions.

The blincyto market research report is one of a series of new reports from The Business Research Company that provides blincyto market statistics, including blincyto industry global market size, regional shares, competitors with a blincyto market share, detailed blincyto market segments, market trends and opportunities, and any further data you may need to thrive in the blincyto industry. This blincyto market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blincyto market size is expected to see strong growth in the next few years. It will grow to $1,022.1 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing shift towards patient-centric care models, increasing availability of injectable therapies, increasing interest from pharmaceutical companies, increasing focus on quality of life improvements, rising incidence of ALL in adults. Major trends in the forecast period include research funding for technological advancements, emergence of bispecific t-cell engagers, advancements in cell therapy, enhanced patient monitoring technologies, improved formulation techniques.

The growing incidence of leukemia is anticipated to drive the expansion of the Blincyto market. Leukemia, a type of cancer originating in blood-forming tissues like bone marrow, causes the overproduction of abnormal white blood cells, which disrupt normal blood cell function. The rise in leukemia cases is linked to factors such as an aging population, environmental exposures, genetic predispositions, and improved diagnostic capabilities. Blincyto plays a critical role in treating leukemia as a bispecific T-cell engager, helping the immune system target and eliminate leukemia cells, especially in patients with acute lymphoblastic leukemia (ALL). For example, in January 2024, the American Cancer Society projected approximately 62,770 new leukemia cases in the United States in 2024, an increase from 59,610 in 2023. As a result, the rising incidence of leukemia is fueling the growth of the Blincyto market.

An increase in healthcare spending is expected to support the growth of the Blincyto market. Healthcare spending encompasses all expenditures on health services and goods, including personal care, public health programs, and health administration. This spending is rising due to factors such as population growth, aging demographics, rising service costs, higher chronic illness prevalence, and advancements in medical technology. The rise in healthcare spending improves access to advanced cancer treatments like Blincyto, facilitating wider adoption and better patient outcomes. For instance, in May 2024, a report from the Office for National Statistics in the UK revealed that healthcare expenditure in the UK reached around $363 billion in 2023, representing a 5.6% increase from the previous year, well above the 0.9% increase in 2022. Consequently, higher healthcare spending is driving the Blincyto market.

A key trend in the Blincyto market is the focus on developing innovative therapies, including immuno-oncology treatments, to target and destroy cancer cells. Immuno-oncology therapies use the body's immune system to recognize and eliminate cancer cells. For example, in June 2024, Amgen Inc., a U.S.-based biotechnology company, received FDA approval for Blincyto (blinatumomab) to treat CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in both adult and pediatric patients, regardless of the presence of measurable residual disease (MRD). Blincyto is a bispecific T-cell engager (BiTE) that binds to CD19 on B-cell tumors and CD3 on T-cells, guiding T-cells to target and destroy cancer cells.

Key player operating in the blincyto market is Amgen Inc.

North America was the largest region in the Blincyto market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blincyto report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blincyto market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blincyto market consists of sales of oncology medications, biosimilars, immunotherapy drugs, anti-inflammatory medications and hematology medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blincyto Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blincyto market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blincyto ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blincyto market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prefilled; Non-Prefilled
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Acute Lymphoblastic Leukemia; Other Hematological Disorders
• 4) By End-User: Hospitals; Clinics; Research Institutions
• Companies Mentioned: Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blincyto Market Characteristics

3. Blincyto Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Blincyto Market Trends And Strategies

5. Blincyto Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Blincyto Growth Analysis And Strategic Analysis Framework

• 6.1. Global Blincyto PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Blincyto Market Growth Rate Analysis
• 6.4. Global Blincyto Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Blincyto Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Blincyto Total Addressable Market (TAM)

7. Global Blincyto Market Pricing Analysis & Forecasts

8. Blincyto Market Segmentation

• 8.1. Global Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prefilled
• Non-Prefilled
• 8.2. Global Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 8.3. Global Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Lymphoblastic Leukemia
• Other Hematological Disorders
• 8.4. Global Blincyto Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutions

9. Global Blincyto Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Blincyto Market Regional And Country Analysis

• 10.1. Global Blincyto Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Blincyto Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Blincyto Market

• 11.1. Asia-Pacific Blincyto Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Blincyto Market

• 12.1. China Blincyto Market Overview
• 12.2. China Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Blincyto Market

• 13.1. India Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Blincyto Market

• 14.1. Japan Blincyto Market Overview
• 14.2. Japan Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Blincyto Market

• 15.1. Australia Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Blincyto Market

• 16.1. South Korea Blincyto Market Overview
• 16.2. South Korea Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Blincyto Market

• 17.1. Western Europe Blincyto Market Overview
• 17.2. Western Europe Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Blincyto Market

• 18.1. UK Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Blincyto Market

• 19.1. Germany Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Blincyto Market

• 20.1. France Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blincyto Market

• 21.1. Eastern Europe Blincyto Market Overview
• 21.2. Eastern Europe Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Blincyto Market

• 22.1. North America Blincyto Market Overview
• 22.2. North America Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Blincyto Market

• 23.1. USA Blincyto Market Overview
• 23.2. USA Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Blincyto Market

• 24.1. Canada Blincyto Market Overview
• 24.2. Canada Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Blincyto Market

• 25.1. South America Blincyto Market Overview
• 25.2. South America Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Blincyto Market

• 26.1. Middle East Blincyto Market Overview
• 26.2. Middle East Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Blincyto Market

• 27.1. Africa Blincyto Market Overview
• 27.2. Africa Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Blincyto Market Competitive Landscape And Company Profiles

• 28.1. Blincyto Market Competitive Landscape
• 28.2. Blincyto Market Company Profiles
  • 28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Blincyto Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Blincyto Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Blincyto Market

32. Recent Developments In The Blincyto Market

33. Blincyto Market High Potential Countries, Segments and Strategies

• 33.1 Blincyto Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Blincyto Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Blincyto Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer